Evidence map›Paper›PMID 25951067›Full record

ArticleKidney international2015

'How long have I got doctor?' The development and validation of a new prognostic model.

R Steenkamp, F J Caskey

Abstract readComment
PubMed Publisher
In one paragraph

Article in Kidney international, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

R SteenkampUK Renal Registry, Learning and Research, Southmead Hospital, Bristol, UK.
F J Caskey1] UK Renal Registry, Learning and Research, Southmead Hospital, Bristol, UK [2] School of Social and Community Medicine, Bristol, UK [3] Renal Unit, Southmead Hospital, North Bristol NHS Trust, Westbury on Trym, Bristol, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the current issue of Kidney International, Floege et al report the development and external validation of a prognostic score for patients starting haemodialysis. The model performs well and appears robust in various sub-groups and in external validation. This commentary takes a systematic approach to considering the generalisability of the results and applicability of the prognostic score to wider clinical practice.

Indexed as

FemaleHumansKidney Failure, ChronicMaleRenal Dialysis

Identifiers

PMID25951067

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.